Key Takeaways
- Sector: Healthcare, Healthtech & Medtech, Consumer.
- Geography: United States.
Analysis
LaserAway, a prominent operator of medical spas and aesthetic dermatology clinics, is reportedly considering a sale that could command a valuation exceeding $2 billion. The Los Angeles-based company, which has seen significant expansion under the backing of Ares Management and Seidler Equity Partners, has enlisted investment bank Harris Williams to guide a potential transaction process. While the discussions are in their nascent stages and no definitive agreement has been reached, the move signals robust investor interest in the rapidly growing non-surgical cosmetic treatment sector.
Founded in 2006, LaserAway has evolved from its initial operations into a nationwide network, offering a comprehensive suite of services including laser hair removal, tattoo removal, skin rejuvenation, and injectables like Botox. The company's business model appears to be performing strongly, with reports indicating annual EBITDA of approximately $150 million. This financial performance is underpinned by a loyal customer base and the recurring revenue inherent in elective aesthetic procedures, a segment that has demonstrated remarkable resilience even in uncertain economic climates.
The aesthetic and medspa industry has become a magnet for private equity investment over the past several years. This sustained attention is driven by attractive unit economics, strong brand loyalty, and the increasing consumer acceptance of cosmetic enhancements. Notable recent transactions in this space include General Atlantic's acquisition of European Wax Center, Stride Consumer Partners' investment in Peachy, Leonard Green & Partners' ownership of Milan Laser, and KKR's support for SkinSpirit, underscoring the sector's appeal to institutional capital.
Ares Management initially invested in LaserAway in 2021, acquiring a substantial minority stake when the company operated 74 locations. Since that investment, LaserAway has experienced a significant growth trajectory, more than tripling its footprint to 219 clinics across the United States. This rapid expansion has positioned the company as a leading national chain in the dermatology and aesthetics field, a feat highlighted by its recent celebration of its 219th clinic opening without any prior closures – a notable achievement in the competitive retail and medical services industries.
The potential sale of LaserAway at a valuation north of $2 billion reflects the premium being placed on scaled, well-managed businesses within the high-growth aesthetic sector. The company's ability to consistently expand its physical presence while maintaining operational integrity and strong financial metrics makes it an attractive target for strategic acquirers or larger private equity firms looking to capitalize on continued market demand for non-invasive cosmetic treatments. The ongoing process, managed by Harris Williams, will be closely watched by industry participants and investors alike.
The broader market for aesthetic procedures is substantial and projected to continue its upward trajectory. Factors such as increased social media influence, greater accessibility to treatments, and a growing emphasis on personal wellness and appearance are contributing to sustained consumer spending. Companies like LaserAway, with their established brands and extensive clinic networks, are well-positioned to capture a significant share of this expanding market, making them prime candidates for significant M&A activity.